Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7,735.00
Bid: 7,728.00
Ask: 7,730.00
Change: 55.00 (0.72%)
Spread: 2.00 (0.03%)
Open: 7,682.00
High: 7,745.00
Low: 7,673.00
Yest. Close: 7,680.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Volunteer In AstraZeneca's Covid Vaccine Test Dies In Brazil

Wed, 21st Oct 2020 20:40

(Alliance News) - A volunteer participating in clinical trials of the Covid-19 vaccine developed by Oxford University and AstraZeneca PLC has died in Brazil, officials said Wednesday, though it was unclear whether he received the vaccine or a placebo.

It is the first death reported in the various coronavirus vaccine trials taking place worldwide. 

However, organizers of the study said an independent review had concluded there were no safety concerns and that testing of the vaccine, developed with pharmaceutical firm AstraZeneca, would continue.

Media reports said the volunteer was a 28-year-old doctor working on the front lines of the pandemic who died of complications from Covid-19.

"All significant medical incidents, whether participants are in the control group or the Covid-19 vaccine group, are independently reviewed," Oxford said in a statement.

"Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial, and the independent review in addition to the Brazilian regulator have recommended that the trial should continue."

National health regulator Anvisa confirmed it had been "formally notified of the case on October 19" and had received a report on the independent review from the security and evaluation committee overseeing the study.

The D'Or Teaching and Research Institute, which is helping organize the tests in Brazil, said the independent review process had "raised no doubts about the safety of the study, and recommended it continue."

Oxford and AstraZeneca previously had to suspend testing of the vaccine in September when a volunteer in the UK developed an unexplained illness.

Trials resumed after British regulators and an independent review concluded the illness was not a side effect of the vaccine.

Half the volunteers in the final-stage clinical trial – a double-blind, randomized, controlled study – receive a placebo, IDOR said.

Around 8,000 volunteers have been vaccinated so far in Brazil, and more than 20,000 worldwide, it said.

Study participants must be doctors, nurses or other health sector workers who come into regular contact with the virus.

Brazilian newspaper Globo said the deceased volunteer was a young doctor who had been treating Covid-19 patients since March in the emergency rooms and intensive care units at two hospitals in Rio de Janeiro.

He graduated from medical school last year, and was in good health prior to contracting the disease, family and friends told the newspaper.

Shares in AstraZeneca closed 1.8% lower at 7,920.00 pence on Wednesday in London.

source: AFP

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

INSIGHT-How the U.S. locked up vaccine materials other nations urgently need

By Allison Martell and Euan RochaMay 7 (Reuters) - To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots.As a result, the U.S. government laid claim n...

Today 16:00

WRAPUP 1-Britain, Germany in role reversal on AstraZeneca vaccine risks

* Britain restricts AstraZeneca to people aged over 40* In Germany, all adults free to get AZ shot on doctor's advice* Germany, with eye on summer hols, shortens gap between doses* EU regulator looking at AZ on reports of neurological illnessBy Al...

Today 15:34

UPDATE 1-Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

(Adds details and background)By Khanh VuHANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot, as the country is battling a new outbreak.A 35-year-old fe...

Today 15:31

Vietnam reports first death in patient who received AstraZeneca COVID-19 vaccine

HANOI, May 7 (Reuters) - Vietnam's health ministry on Friday reported its first death in a patient who received AstraZeneca's COVID-19 vaccine shot.A 35-year-old female health worker in the southern province of An Giang died on Friday, one day aft...

Today 14:54

UPDATE 1-EU regulator reviews reports of rare nerve disorder after AstraZeneca shot

(Adds details from EMA statement on other vaccines, background)May 7 (Reuters) - Europe's medicines regulator said on Friday it was reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZeneca's COVID-19 vaccine,...

Today 13:15

UPDATE 2-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviewing AstraZeneca vaccine for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA also assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (...

Today 13:15

UPDATE 3-EU reviews reports of rare nerve disorder after AstraZeneca's COVID-19 shot

* EMA reviews AstraZeneca shot for Guillain-Barre syndrome* Rare nerve syndrome also linked some vaccinations in past* EMA assessing heart inflammation with Pfizer, Moderna shots* Studies into possible links to rare blood clots ongoing (Adds BioNTe...

Today 13:15

Canada willing to discuss COVID-19 vaccine IP waiver -statement

OTTAWA, May 7 (Reuters) - Canada on Friday said that it was ready to discuss an intellectual property rights (IP) waiver for COVID-19 vaccines while it also recognized the importance of protecting IP and the integral role industry played in devel...

Today 13:00

UPDATE 1-German panel to recommend J&J COVID vaccine for over-60s - Spiegel

(Adds RKI comment, background)BERLIN, May 7 (Reuters) - Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing...

Today 12:24

Germany's STIKO to recommend J&J COVID vaccine for over-60s - Spiegel

BERLIN, May 7 (Reuters) - Germany's vaccine committee, known as STIKO, plans to recommend Johnson & Johnson's COVID-19 vaccine only for people over the age of 60, German magazine Der Spiegel reported on Friday, citing no sources.Europe's drug regu...

Today 11:58

New UK guidance on AstraZeneca will not affect rollout schedule- official

LONDON, May 7 (Reuters) - Britain's decision to advise all under 40-year-olds to take an alternative vaccine to the Oxford/AstraZeneca one will not affect the country's plan to offer a first dose to all adults by the end of July, a senior health ...

Today 11:43

UPDATE 1-Third wave of pandemic "appears to be broken" - German health minister

(Adds detail on vaccination progress, AstraZeneca decision)BERLIN, May 7 (Reuters) - The third wave of the coronavirus pandemic appears to be broken, German Health Minister Jens Spahn said on Friday, as social distancing measures and an accelerati...

Today 09:54

UPDATE 2-Germany defends AstraZeneca pivot as key to speeding vaccinations

* All adults now free to get AZ shot, on doctor's advice* Gap between doses can be as little as 4 weeks* Experts warn on reduced efficacy with shorter gap* Third wave of pandemic "appears to be broken" - minister (Recasts to lead on AstraZeneca shif...

Today 09:54

UK to give under 40s alternative to AstraZeneca vaccine

(Sharecast News) - The UK government decided on Friday to offer people under 40 an alternative to the AstraZeneca Covid-19 vaccine, reported Bloomberg.

Today 09:49

Germany says production capacity, not patents, key to upping vaccine output

BERLIN, May 7 (Reuters) - The main challenge to raising production of COVID-19 vaccines is how to quickly and effectively transfer technology, Germany's health minister said Friday, reiterating Berlin's opposition to a U.S. proposal to waive pate...

Today 09:23

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.